Innovating Works

LUNGS EUROPE

Desconocido
RESPIRE-EXCEL: Respiratory Precision Medicine PhD Training Network Excellence through Systems Biology Spatial and... LUNGS EUROPE participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-si...
2024-07-01 - 2029-02-28 | Financiado
EU PAL-COPD: Evaluation of the ICLEAR-EU intervention to integrate palliative care in the treatment of people wit... LUNGS EUROPE participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Chronic Obstructive Pulmonary Disease (COPD) is a devastating life-limiting lung disease with a high personal and societal burden. Worldwide...
2023-12-08 - 2028-12-31 | Financiado
OPTIMA: Optimal treatment for patients with solid tumours in Europe through Artificial intelligence LUNGS EUROPE participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage OPTIMA is a multi-stakeholder-led consortium with the vision that each and every patient should have access to the most up-to-date individua...
2021-10-18 - 2026-09-30 | Financiado
UNITE4TB: ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS LUNGS EUROPE participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Current anti-tuberculosis (TB) drug regimens face serious limitations at times of increasing antimicrobial drug resistance. Fortunately, for...
2021-06-29 - 2028-05-31 | Financiado
DRAGON: The RapiD and SecuRe AI enhAnced DiaGnosis Precision Medicine and Patient EmpOwerment Centered Deci... LUNGS EUROPE participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage In this project, a multinational consortium of high-tech SMEs, academic research institutes, biotech and pharma partners, affiliated patient...
2020-10-22 - 2024-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.